New York, NY -- (SBWIRE) -- 01/03/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Graphic Packaging Holding Company (NYSE:GPK), Penn West Petroleum Ltd (USA) (NYSE:PWE), PDL BioPharma Inc (NASDAQ:PDLI), LeapFrog Enterprises, Inc (NYSE:LF)
Graphic Packaging Holding Company (NYSE:GPK) showed a volume of 2.53 million shares by the end of last trade whereas the average volume of the stock remained 2.90 million shares. The stock opened the session at $9.55 but then moved to $09.48. At that price, the stock showed a negative performance of -1.25%. Graphic Packaging Holding Company (GPHC) is a provider of packaging solutions for a variety of products to food, beverage and other consumer products companies. It is also a producer of folding cartons and coated unbleached kraft paperboard, coated-recycled board and multi-wall bags. The Company operates in two business segments: paperboard packaging and flexible packaging.
Will GPK Get Buyers Even After The Recent Rally? Find Out Here
Penn West Petroleum Ltd (USA) (NYSE:PWE) opened the session at $8.35and closed the session at $8.60. The stock showed a positive performance of 2.87% in previous trading session. Penn West Petroleum Ltd. (Penn West), formerly Penn West Energy Trust, is a Canadian exploration and production company. Penn West is engaged in the business of acquiring, exploring, developing, exploiting and holding interests in petroleum and natural gas properties and related assets. Penn West participates in the exploration for, and the development and production of,
For How Long PWE will fight for Profitability? Read This Trend Analysis report
PDL BioPharma Inc (NASDAQ:PDLI) opened the session at $8.45 and closed the session at $8.54. The stock showed a positive performance of 1.18% in previous trading session. The beta of the stock remained 0.62. PDL BioPharma, Inc. (PDL) is a is a biotech company. PDL is engaged in the management of antibody humanization patents and royalty assets, which consist of its Queen et al. patents and license agreements with various biotechnology and pharmaceutical companies.
Why Should Investors Buy PDLI After The Recent Gain? Just Go Here and Find Out
LeapFrog Enterprises, Inc (NYSE:LF) the stock decreased -0.88% and finished the session at $7.87. Traded with volume of 2.49 million shares in the prior session and the average volume of the stock remained 1.51 million shares. The beta of the stock remained 2.22. LeapFrog Enterprises, Inc. (LeapFrog) is a developer of educational entertainment for children. The Company’s product portfolio consists of multimedia learning platforms and related content and learning toys. The Company has developed a number of learning platforms, including the LeapPad Explorer (LeapPad) learning tablet, the Leapster family of multimedia learning platforms and the Tag and Tag Junior reading systems, which supports a library of content titles.
Will LF Get Buyers Even After The Recent Rally? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)